Status: Investigational/controlled
The most frequently reported reactions include: Redness (erythema) at the application site Itching or a tingling/stinging sensation , especially on freshly exfoliated or compromised skin Dryness or mild flaking , sometimes related to the overall formulation rather than the peptide itself Temporary irritation when combined with strong actives These reactions typically resolve on their own or after reducing frequency of use
search "BPC-157 systematic review" on PubMed) ACS Labs and WuXi AppTec analytical testing roundups on COA discrepancy rates in research-use-only peptide vendors PeptideLaws and Lumalex Law, trade coverage of Peptide Sciences voluntary shutdown, March 6, 2026 Orrick and Polsinelli law firm client alerts on FDA PCAC scheduling for BPC-157, TB-500, epitalon, and related peptides, 2026
What Changed, and What Didnt In late 2023, the FDA moved 19 widely used peptides to its Category 2 list, effectively banning compounding pharmacies from preparing them
After you reconstitute your Glow 70 Peptide with bacteriostatic water, ensure to refrigerate it
Our Beverly Hills providers tailor it after a medical consultation based on your skin and recovery goals